Profile
Virginie Carmignac founded Termino C 2436 AB in 2011.
Ms. Carmignac is also the founder of Merozyne Therapeutics AB.
Virginie Carmignac active positions
Companies | Position | Start |
---|---|---|
Merozyne Therapeutics AB
Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Founder | - |
Former positions of Virginie Carmignac
Companies | Position | End |
---|---|---|
Termino C 2436 AB
Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Termino C 2436 AB
Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Health Technology |
Merozyne Therapeutics AB
Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Health Technology |
- Stock Market
- Insiders
- Virginie Carmignac